Tenders of Gwq Serviceplus Ag

Tenders of Gwq Serviceplus Ag

Gwq Serviceplus Ag Tender

Germany
Closing Date11 Aug 2025
Tender AmountRefer Documents 
Germany-düsseldorf: Pharmaceutical Products

Gwq Serviceplus Ag Tender

Healthcare and Medicine...+1Chemical Products
Germany
Closing Date10 May 2026
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements pursuant to Section 130 A Paragraph 8 SGB V with the active ingredient brimonidine in the dosage form Edp

Gwq Serviceplus Ag Tender

Germany
Closing Date10 Aug 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarung Nach § 130a Abs. 8 Sgb V Zu Wirkstoffen (arzneimitteln) - Vv_79

Gwq Serviceplus Ag Tender

Electrical and Electronics
Germany
Closing Date10 May 2025
Tender AmountRefer Documents 
Germany-düsseldorf: Pharmaceutical Products

Gwq Serviceplus Ag Tender

Germany
Closing Date11 Aug 2025
Tender AmountRefer Documents 
Germany-düsseldorf: Pharmaceutical Products

Gwq Serviceplus Ag Tender

Electrical and Electronics
Germany
Closing Date9 May 2025
Tender AmountRefer Documents 
Germany-düsseldorf: Pharmaceutical Products

Gwq Serviceplus Ag Tender

Others
Germany
Closing Date10 May 2026
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V In Der Zeit Vom 01.01.2025 - 30.06.2026

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Closing Date10 May 2026
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements pursuant to Section 130 A Paragraph 8 SGB V with the active ingredient bevacizumab

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Closing Date10 Nov 2025
Tender AmountRefer Documents 
Germany – Pharmaceutical Products – Auftragsbekanntmachung - Abschluss Nicht-exklusiver Rabattvereinbarungen Nach § 130 A Abs. 8 Sgb V Zu Arzneimitteln Mit Dem Wirkstoff Baricitinib

Gwq Serviceplus Ag Tender

Healthcare and Medicine
Germany
Closing Date11 Aug 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements according to § 130a paragraph 8 Sgb V for the active substance Natalizumab Ilo
161-170 of 190 active Tenders